Yitao Ou

780 total citations
19 papers, 603 citations indexed

About

Yitao Ou is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Yitao Ou has authored 19 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Immunology and 4 papers in Surgery. Recurrent topics in Yitao Ou's work include Inflammasome and immune disorders (12 papers), Liver physiology and pathology (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Yitao Ou is often cited by papers focused on Inflammasome and immune disorders (12 papers), Liver physiology and pathology (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Yitao Ou collaborates with scholars based in China, United States and Australia. Yitao Ou's co-authors include Ping Sun, Wenhui Hu, Zhongjin Yang, Guizhi Yang, Yue Hu, Tian Lan, Changzheng Li, Genshu Wang, Jiao Guo and Lei Hua and has published in prestigious journals such as Hepatology, Brain Research and Free Radical Biology and Medicine.

In The Last Decade

Yitao Ou

19 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yitao Ou China	13	300	145	121	117	71	19	603
Xiaoju Li China	15	240 0.8×	96 0.7×	45 0.4×	38 0.3×	136 1.9×	46	546
Xiaodong Peng China	18	410 1.4×	84 0.6×	182 1.5×	44 0.4×	74 1.0×	49	873
Lei Yan China	10	248 0.8×	88 0.6×	47 0.4×	48 0.4×	130 1.8×	40	569
Wang‐Xiang Xu China	12	475 1.6×	122 0.8×	69 0.6×	111 0.9×	87 1.2×	23	755
Tixiao Wang China	12	290 1.0×	123 0.8×	257 2.1×	69 0.6×	73 1.0×	18	654
Fanping Meng China	16	258 0.9×	185 1.3×	99 0.8×	173 1.5×	84 1.2×	38	748
Jinxing Quan China	12	202 0.7×	129 0.9×	88 0.7×	38 0.3×	59 0.8×	41	518
Xi Jiang China	14	366 1.2×	200 1.4×	173 1.4×	59 0.5×	48 0.7×	27	740
Yifei Lv China	12	241 0.8×	164 1.1×	52 0.4×	73 0.6×	75 1.1×	20	567

Countries citing papers authored by Yitao Ou

Since Specialization

Citations

This map shows the geographic impact of Yitao Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yitao Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yitao Ou more than expected).

Fields of papers citing papers by Yitao Ou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yitao Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yitao Ou. The network helps show where Yitao Ou may publish in the future.

Co-authorship network of co-authors of Yitao Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Yitao Ou. A scholar is included among the top collaborators of Yitao Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yitao Ou. Yitao Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Ou, Yitao, Zhongjin Yang, Yue Hu, et al.. (2024). Antagonizing interleukin-5 receptor ameliorates dextran sulfate sodium-induced experimental colitis in mice through reducing NLRP3 inflammasome activation. European Journal of Pharmacology. 965. 176331–176331. 4 indexed citations

Yang, Xiangyu, Lin Geng, Xueping Lei, et al.. (2024). Chlorquinaldol Alleviates Lung Fibrosis in Mice by Inhibiting Fibroblast Activation through Targeting Methionine Synthase Reductase. ACS Central Science. 10(9). 1789–1802. 4 indexed citations

Yang, Zhongjin, Yitao Ou, Lin Geng, et al.. (2023). Discovery of a selective NLRP3-targeting compound with therapeutic activity in MSU-induced peritonitis and DSS-induced acute intestinal inflammation. Cellular and Molecular Life Sciences. 80(8). 230–230. 10 indexed citations

Hua, Lei, Shuli Liang, Xinyi Wu, et al.. (2022). Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis. International Immunopharmacology. 113(Pt B). 109431–109431. 24 indexed citations

Chen, Yanhong, Shuli Liang, Yitao Ou, et al.. (2022). Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Chemico-Biological Interactions. 365. 110122–110122. 10 indexed citations

Liang, Shuli, Zhongjin Yang, Lei Hua, et al.. (2022). Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice. European Journal of Pharmacology. 930. 175156–175156. 11 indexed citations

Hao, Ying, Yitao Ou, Cheng Zhang, et al.. (2022). Seratrodast, a thromboxane A2 receptor antagonist, inhibits neuronal ferroptosis by promoting GPX4 expression and suppressing JNK phosphorylation. Brain Research. 1795. 148073–148073. 12 indexed citations

Chen, Yanhong, Yitao Ou, Shuli Liang, et al.. (2022). Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation. Biochemical Pharmacology. 206. 115326–115326. 18 indexed citations

Wu, Xinyi, Ping Sun, Lei Hua, et al.. (2022). Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity. Journal of Medicinal Chemistry. 65(18). 11985–12001. 12 indexed citations

10.

Hu, Yue, Zhongjin Yang, Yitao Ou, et al.. (2021). Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation. International Immunopharmacology. 97. 107819–107819. 25 indexed citations

11.

Zhang, Cheng, Yue Hu, Ping Sun, et al.. (2021). Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities. European Journal of Medicinal Chemistry. 219. 113417–113417. 26 indexed citations

12.

Ou, Yitao, Ping Sun, Nannan Wu, et al.. (2020). Synthesis and biological evaluation of parthenolide derivatives with reduced toxicity as potential inhibitors of the NLRP3 inflammasome. Bioorganic & Medicinal Chemistry Letters. 30(17). 127399–127399. 14 indexed citations

13.

Yang, Zhongjin, et al.. (2020). Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation. Free Radical Biology and Medicine. 152. 8–17. 71 indexed citations

14.

Sun, Ping, Yue Hu, Yitao Ou, et al.. (2020). Compound AD16 Reduces Amyloid Plaque Deposition and Modifies Microglia in a Transgenic Mouse Model of Alzheimer’s Disease. ACS Pharmacology & Translational Science. 3(6). 1100–1110. 11 indexed citations

15.

Sun, Ping, Wei Zhou, Yue Hu, et al.. (2020). Compound AD110 Acts as Therapeutic Management for Alzheimer’s Disease and Stroke in Mouse and Rat Models. ACS Chemical Neuroscience. 11(6). 929–938. 13 indexed citations

16.

Lan, Tian, Changzheng Li, Guizhi Yang, et al.. (2018). Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2. Hepatology. 68(3). 1070–1086. 126 indexed citations

17.

Chen, Yinghua, Yitao Ou, Jiale Dong, et al.. (2017). Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition. Experimental Cell Research. 362(2). 343–348. 42 indexed citations

18.

Li, Changzheng, Yitao Ou, Ning Li, et al.. (2016). Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway. Molecular and Cellular Endocrinology. 437. 268–279. 95 indexed citations

19.

Lan, Tian, Changzheng Li, Lingyun Zheng, et al.. (2015). Activation of Slit2-Robo1 signaling promotes liver fibrosis. Journal of Hepatology. 63(6). 1413–1420. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact